United Therapeutics (UTHR) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $563.70 +3.01%
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +1.5%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $6.63, $0.10 better than the analyst estimate of $6.53. Revenue for the quarter came in at $794.4 million versus the consensus estimate of $728.34 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts Holley (HLLY) at Buy
- Enerpac Tool Group to buy SFE Group for $472 million
- ExxonMobil outlines key factors for Q2 2026 earnings outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
